Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, UgenTec to Launch Sample-to-Answer PCR Workflows

NEW YORK — Tecan said on Thursday that it has partnered with Belgian molecular diagnostics software developer UgenTec to combine their respective technologies for integrated sample-to-answer PCR workflows.

Under the terms of their deal, the companies will market Tecan's liquid handling and automation workstations in combination with UgenTec's FastFinder PCR analysis software to diagnostics laboratories. Tecan said that the combined offering will also form the basis of vitro diagnostics platforms developed through its Synergence original equipment manufacturer service.

Financial and other terms of the agreement were not disclosed.

Both companies have struck other partnerships in the past. About a year ago, Switzerland-based Tecan began working with Zymo Research to launch a viral DNA/RNA extraction product. Around that same time, UgenTec partnered with LGC Biosearch Technologies on a SARS-CoV-2 detection workflow.




The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.